Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Aims</h3><p>Accumulating studies identified that BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) is integrally involved in the initiation and development of tumors. Nevertheless, the precise biological role and underlying mechanisms of BUB1B in hepatocellular carcinoma (HCC) remain indistinct.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Method</h3><p>To figure out the role of BUB1B in HCC, we first assessed its expression using The Cancer Genome Atlas (TCGA) and Gene Expression Profiling Interactive Analysis (GEPIA) databases. We then verified BUB1B expression in HCC tissues, nontumor tissues, and HCC cell lines through western blotting, quantitative reverse transcription‐polymerase chain reaction, and immunohistochemistry. To explore the specific function of BUB1B in HCC in vivo and in vitro, we performed the flow cytometry, Cell Counting Kit‐8, 5‐ethynyl‐2′‐deoxyuridine incorporation, colony formation, Transwell, wound‐healing, subcutaneous tumor growth, and metastasis assays. Additionally, we identified the BUB1B‐regulated pathways involved in HCC by using gene set enrichment analysis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Our data displayed that higher BUB1B expression was detected in HCC tissues and HCC cell lines. The overexpression of BUB1B was positively correlated with adverse clinicopathological characteristics. Survival analyses showed that lower recurrence‐free and overall survival rates were correlated with the overexpression of BUB1B in patients with HCC. Moreover, the malignancy of HCC was facilitated by BUB1B both in vivo and in vitro. Lastly, the results were confirmed by western blots, which showed that BUB1B upregulated mTORC1 signaling pathway in HCC. Meanwhile, the oncogenic effect of BUB1B will be impaired when the mTORC1 signaling pathway was inhibited by rapamycin.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>We highlighted that BUB1B played an oncogenic role in HCC and was identified as a possible clinical prognostic factor and a potential novel therapeutic target for HCC.</p></section>

Budding uninhibited by benzimidazoles 1 might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype in lung adenocarcinoma

The Predictive Value of BUB1 in the Prognosis of Oral Squamous Cell Carcinoma

Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma.

Comprehensive analysis of BUBs gene family in lung adenocarcinoma with immunological analysis

Quantitative proteomics analysis of papillary thyroid carcinoma reveals PROS1, CLU, and LRG1 as potential novel prognostic protein biomarkers

Overexpression of BubR1 Mitotic Checkpoint Protein Predicts Short Survival and Influences the Progression of Cholangiocarcinoma

Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma Via Regulating the Cell Cycle

XBP1s Acts as a Tumor Suppressor to Inhibit the EMT Process and Metastasis of Papillary Thyroid Cancer

BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway

BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma

Overexpression of BUB1B Contributes to Progression of Prostate Cancer and Predicts Poor Outcome in Patients with Prostate Cancer

Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies

CITED1 Contributes to the Progression of Papillary Thyroid Carcinoma Via the Wnt/β-catenin Signaling Pathway

Prognostic Values of Spindle Checkpoint Protein BUB1B in Triple Negative Breast Cancer

BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway

Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma

Ott_a_215025 6769..6777

Characterization of the Novel Tumor-Suppressor Gene CCDC67 in Papillary Thyroid Carcinoma.

CITED1 Promotes Proliferation of Papillary Thyroid Cancer Cells Via the Regulation of P21 and P27.

BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways